Sunday, November 29, 2015

UCity Science Center draws investor, Euro sales, lab

Five new tenants for the Port Business Incubator

UCity Science Center draws investor, Euro sales, lab


University City Science Center, the West Philly landlord co-owned by Penn, Drexel and nearby schools, says it's drawn five new tenants to its "Port Business Incubator" at 3711 and 3624 Market St. The Center says the new arrivals include:

  - Karlin Asset Management, a $1 billion-asset investment firm. Armen Karamian will run the office, "focusing on early-stage investments"
  - Claremont, a subsidiary of France-based Ballina Capital. Claremont markets the Nd:YAP dental laser. US sales boss Blandine Chantepie says the firm was drawn to UCity by another French tenant, ERAI.
  - Epitek Inc., which says it's developing radiation protection and therapy and "regenerative medicine" technologies in collaboration with scientists at Temple U and the U of Texas.
  - Longevity Biotech, developer of Hybridtide, which is supposed to reduce drug resistence for "novel therapies." The firm, "spun out of the University of Wisconsin," has a contract with Philadelphia-based Fox Chase Cancer Center. 
  - Parsortix Inc., a "particle separation company" that pulls biological samples from fluid suspensions using "unconventional methods." The firm has been funded by Angle Technology Ventures LLC and Ben Franklin Technology Partners of Southeastern Pennsylvania. 

We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog

PhillyDeals posts interviews, drafts and updates that Joseph N. DiStefano writes alongside his Sunday and Monday columns and ongoing articles about Philadelphia-area business.

DiStefano studied economics, history and a little engineering at Penn. He taught writing and research at St. Joe’s. He has written for the Inquirer since 1989, except when he left a few times to work at Bloomberg and elsewhere. He wrote the book Comcasted, and raised six kids with his wife, who is a saint.

Reach Joseph N. at, 215.854.5194, @PhillyJoeD. Read his blog posts at and his Inquirer columns at Bloomberg posts his items at NH BLG_PHILLYDEAL.

Reach Joseph at or 215 854 5194.

Joseph DiStefano
Also on
letter icon Newsletter